Treatment groups | Serum cholesterol (mg/dl) | Atherosclerotic index | LDL-C/HDL-C ratio | ||
---|---|---|---|---|---|
Total cholesterol | HDL-C | LDL-C | |||
SP-control | 74.63 ± 11.31a | 53.38 ± 7.78a | 4.25 ± 3.11a | 0.40 ± 0.06a | 0.08 ± 0.01a |
SP-2 g | 74.00 ± 10.73a | 52.13 ± 6.66a | 3.50 ± 2.00a | 0.42 ± 0.04ab | 0.07 ± 0.04ab |
HFC-control | 150.29 ± 20.51c | 48.00 ± 8.41a | 58.67 ± 7.76d | 2.13 ± 0.71c | 1.22 ± 0.15c |
HFC-1 g | 102.86 ± 22.22b | 54.43 ± 7.55a | 36.71 ± 9.69c | 0.89 ± 0.19b | 0.67 ± 0.12b |
HFC-2 g | 95.63 ± 19.98ab | 51.63 ± 7.95a | 30.88 ± 12.10bc | 0.85 ± 0.18ab | 0.60 ± 0.18ab |
HFC-rosuvastatin | 85.57 ± 16.23ab | 50.29 ± 9.91a | 19.71 ± 5.91b | 0.70 ± 0.10ab | 0.39 ± 0.10ab |